Published • loading... • Updated
Supreme Court temporarily extends women’s access to a widely used abortion pill
Justice Samuel Alito’s order keeps telehealth and mail access in place while the justices weigh emergency appeals from drugmakers and Louisiana.
- Justice Samuel Alito issued an order Monday maintaining access to the abortion pill mifepristone while the Supreme Court considers whether to allow restrictions imposed by the 5th Circuit Court to take effect.
- Louisiana filed a lawsuit to roll back Food and Drug Administration rules on mifepristone, claiming the policy undermines state bans; a 5th Circuit Court panel previously ruled mail access and telehealth visits should be suspended.
- Abortion opponents have challenged mifepristone safety for more than 25 years, alleging the FDA violated federal law by overlooking safety issues, despite the agency deeming the drug safe and effective.
- Pharmaceutical companies and Democratic members of Congress cautioned the Supreme Court against limiting access, while President Donald Trump and his Republican administration declined to file a brief despite federal regulations at issue.
- The Supreme Court addresses this controversy four years after overturning Roe v. Wade, though Justice Samuel Alito and Justice Clarence Thomas previously dissented against blocking Circuit Court restrictions on the drug.
Insights by Ground AI
145 Articles
145 Articles
The debate surrounding medical abortions is occupying US courts. Now the Supreme Court has ruled that medications containing the active ingredient mifepristone may be shipped, but only for a short time. Source link: https://www.spiegel.de/ausland/oberstes-us-gericht-erlaubt-postversand-von-abtreibungspillen-vorerst-weiter-a-1462d9d9-6c4b-458d-8215-5a472ea1afbd#ref=rss Author: Publish date: 2026-05-12 02:12:00 Copyright for syndicated content bel…
Coverage Details
Total News Sources145
Leaning Left38Leaning Right19Center69Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 30%
C 55%
15%
Factuality
To view factuality data please Upgrade to Premium
